Keyword Connections

mild cognitive impairment

Journals

26

1 Scientific reports

2 PloS one

3 australasian psychiatry : bulletin of royal australian and new zealand college of psychiatrists

4 Frontiers in psychology

5 neural networks : the official journal of the international neural network society

6 JAMA

7 Journal of Alzheimer's disease : JAD

8 ieee/acm transactions on computational biology and bioinformatics

9 frontiers in aging neuroscience

10 alzheimer's & dementia (new york, n y)

11 neuroimage clinical

12 neurobiology of aging

13 journal of experimental psychology human perception and performance

14 Journal of speech, language, and hearing research : JSLHR

15 Optics express

16 Alzheimer's research & therapy

17 Aging

18 international journal of geriatric psychiatry

19 dementia and geriatric cognitive disorders

20 Medical image analysis

21 current alzheimer research

22 Annals of emergency medicine

23 Journal of neural transmission (Vienna, Austria : 1996)

24 The journal of prevention of Alzheimer's disease

25 BMC complementary medicine and therapies

26 Med (New York, N.Y.)

Research Groups

0

No Research Group Connected

Bibliographies

88

1 Cognitive effects of dance-movement intervention in a mixed group of seniors are not dependent on hippocampal atrophy.

2 Regional brain atrophy predicts time to conversion to Alzheimer's disease, dependent on baseline volume.

3 The case-finding study: A novel community-based research recruitment approach for engaging participants with early cognitive decline.

4 Multi-modal neuroimaging feature selection with consistent metric constraint for diagnosis of Alzheimer's disease.

5 A novel multi-modal machine learning based approach for automatic classification of EEG recordings in dementia.

6 Potential application of Aloe Vera-derived plant-based cell in powering wireless device for remote sensor activation.

7 Seeing pressure in color based on integration of highly sensitive pressure sensor and emission tunable light emitting diode.

8 Electrochemical micro analytical device interfaced with portable potentiostat for rapid detection of chlorpyrifos using acetylcholinesterase conjugated metal organic framework using Internet of things.

9 Toward self-powered and reliable visible light communication using amorphous silicon thin-film solar cells.

10 Semantic Relations in a Categorical Verbal Fluency Test: An Exploratory Investigation in Mild Cognitive Impairment.

11 Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.

12 Lifestyle Factors and Subjective Cognitive Impairment in Patients Seeking Help at a Memory Disorder Clinic: The Role of Negative Life Events.

13 Narrative impairment, white matter damage and CSF biomarkers in the Alzheimer's disease spectrum.

14 Connected Speech Deficit as an Early Hallmark of CSF-defined Alzheimer's Disease and Correlation with Cerebral Hypoperfusion Pattern.

15 Diurnal Cortisol Dynamics, Perceived Stress, and Language Production in Aphasia.

16 Impact of cognitive reserve on clinical and neuropsychological measures in patients with mild cognitive impairment.

17 Individual differences in lapses of sustained attention: Ocolumetric indicators of intrinsic alertness.

18 A Comparison of Divergent Thinking Abilities Between Healthy Elderly Subjects and MCI Patients: Preliminary Findings and Implications.

19 sugihara causality analysis of scalp eeg for detection of early alzheimer's disease

20 specific cognitive domains and symptoms of depression as predictors of activities of daily living in older adults with heterogeneous cognitive backgrounds

21 brain-derived neurotrophic factor serum levels correlate with cognitive performance in parkinson’s disease patients with mild cognitive impairment

22 The effects of six months Persicaria minor extract supplement among older adults with mild cognitive impairment: a double-blinded, randomized, and placebo-controlled trial.

23 apolipoprotein eε4: a biomarker for executive dysfunction among parkinson's disease patients with mild cognitive impairment

24 mild cognitive disorders are associated with different patterns of brain asymmetry than normal ageing: the path through life study

25 graph theoretic analysis of structural connectivity across the spectrum of alzheimer's disease: the importance of graph creation methods

26 Predicting the progression of mild cognitive impairment using machine learning: A systematic, quantitative and critical review.

27 association of pancreatic polypeptide with mild cognitive impairment varies by apoe ε4 allele

28 neural correlates of spatial navigation changes in mild cognitive impairment and alzheimer’s disease

29 subregional structural alterations in hippocampus and nucleus accumbens correlate with the clinical impairment in patients with alzheimer’s disease clinical spectrum: parallel combining volume and vertex-based approach

30 the neural correlates of unsuccessful memory performance in mci

31 brain-wide slowing of spontaneous alpha rhythms in mild cognitive impairment

32 improving csf biomarkers’ performance for predicting progression from mild cognitive impairment to alzheimer’s disease: a meta-analysis

33 allocentric spatial memory testing predicts conversion from mild cognitive impairment to dementia: an initial proof-of-concept study

34 measuring sleep quality in older adults: a comparison using subjective and objective methods.

35 123i-fp-cit spect imaging in early diagnosis of dementia in patients with and without a vascular component

36 altered functional connectivity of the basal nucleus of meynert in mild cognitive impairment: a resting-state fmri study

37 intraindividual variability across cognitive tasks as a potential marker for prodromal alzheimer’s disease

38 precocious alterations of brain oscillatory activity in alzheimer’s disease: a window of opportunity for early diagnosis and treatment

39 Measurement of CSF α‐synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer’s disease

40 Polygenic effects on the risk of Alzheimer's disease in the Japanese population.

41 RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial.

42 Olgotrelvir, a dual inhibitor of SARS-CoV-2 M and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19.

43 Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment.

44 Novel Face-Name Paired Associate Learning and Famous Face Recognition in Mild Cognitive Impairment: A Neuropsychological and Brain Volumetric Study.

45 Significant association of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) rs3846662 and sirtuin 1 (SIRT1) rs7895833 and apolipoprotein E (APOE) hypermethylation with mild cognitive impairment (MCI).

46 Physician Practice Patterns Associated with Diagnostic Evaluation of Patients with Suspected Mild Cognitive Impairment and Alzheimer’s Disease

47 Longitudinal analysis of risk factors for dementia based on Mild Cognitive Impairment Screen results and questionnaire responses from healthy Japanese individuals registered in an online database.

48 Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease.

49 Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review.

50 Risk estimation before progression to mild cognitive impairment and Alzheimer's disease: an AD resemblance atrophy index.

51 Investigation of Cerebral Hemodynamic Changes in Mild Cognitive Impairment Due to Alzheimer’s Disease During a Verbal Fluency Task

52 Differentiating between Alzheimer's disease, amnestic mild cognitive impairment, and normal aging via diffusion kurtosis imaging

53 Screening older adults for amnestic mild cognitive impairment and early-stage Alzheimer’s disease using upper-extremity dual-tasking

54 Electroencephalography reveals lower regional blood perfusion and atrophy of the temporoparietal network associated with memory deficits and hippocampal volume reduction in mild cognitive impairment due to Alzheimer’s disease

55 Cognitive training and neuroplasticity in mild cognitive impairment (COG-IT): protocol for a two-site, blinded, randomised, controlled treatment trial.

56 The Transfer Effects of Cognitive Training on Working Memory Among Chinese Older Adults With Mild Cognitive Impairment: A Randomized Controlled Trial.

57 The effects of mindfulness and health education programs on the emotional state and cognitive function of elderly individuals with mild cognitive impairment: A randomized controlled trial

58 MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements.

59 Fractal dimension of cerebral white matter: A consistent feature for prediction of the cognitive performance in patients with small vessel disease and mild cognitive impairment.

60 Prevalence and Risk Factors of Mild Cognitive Impairment in Menopausal Women at HRH Princess Maha Chakri Sirindhorn Medical Center

61 Brain network alterations in individuals with and without mild cognitive impairment: Parallel independent component analysis of AV1451 and AV45 positron emission tomography

62 Alterations of default mode functional connectivity in individuals with end-stage renal disease and mild cognitive impairment

63 Recognition of Famous and Unfamiliar Faces among Patients Suffering from Amnesia Mild Cognitive Impairment (AMCI) and Alzheimer's Disease.

64 A new tool to assess amnestic mild cognitive impairment in Turkish older adults: virtual supermarket (VSM).

65 Mild cognitive impairment understanding: an empirical study by data-driven approach.

66 The Games for Older Adults Active Life (GOAL) Project for People With Mild Cognitive Impairment and Vascular Cognitive Impairment: A Study Protocol for a Randomized Controlled Trial

67 the effects of acupuncture at real or sham acupoints on the intrinsic brain activity in mild cognitive impairment patients

68 hippocampal volumes among older indian adults: comparison with alzheimer's disease and mild cognitive impairment

69 errors in conducting screening for mild cognitive impairment with hindi mental state examination

70 improved diagnostic multimodal biomarkers for alzheimer’s disease and mild cognitive impairment

71 serum soluble adhesion molecules and markers of systemic inflammation in elderly diabetic patients with mild cognitive impairment and depressive symptoms

72 dietary mineral intake and risk of mild cognitive impairment: the path through life project.

73 p300 and neuropsychological assessment in mild cognitive impairment and alzheimer dementia

74 the role of apolipoprotein e (apoe) genotype in early mild cognitive impairment (e-mci)

75 executive functions as predictors of functional performance in mild alzheimer's dementia and mild cognitive impairment elderly funções executivas como preditores do desempenho funcional em idosos com demência de alzheimer em fase inicial e comprometimento cognitivo leve

76 Detection of mild cognitive impairment and Alzheimer's disease using dual-task gait assessments and machine learning

77 weighted-permutation entropy analysis of resting state eeg from diabetics with amnestic mild cognitive impairment

78 using regional homogeneity to reveal altered spontaneous activity in patients with mild cognitive impairment

79 influence of apoe and rnf219 on behavioral and cognitive features of female patients affected by mild cognitive impairment or alzheimer’s disease

80 cognitive training and transcranial direct current stimulation for mild cognitive impairment in parkinson’s disease: a randomized controlled trial

81 assessment of impairment in activities of daily living in mild cognitive impairment using an individualized scale

82 declines in connected language are associated with very early mild cognitive impairment: results from the wisconsin registry for alzheimer’s prevention

83 effect of toki-shakuyaku-san on regional cerebral blood flow in patients with mild cognitive impairment and alzheimer's disease

84 A machine learning-based linguistic battery for diagnosing mild cognitive impairment due to Alzheimer’s disease

85 Screening for mild cognitive impairment: If not now, when?

86 <sup>18</sup>F-FDG Is a Superior Indicator of Cognitive Performance Compared to <sup>18</sup>F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis

87 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

88 Predicting conversion from mild cognitive impairment to Alzheimer's disease: a multimodal approach.